OMER Stock Summary and Trading Ideas (Omeros | NASDAQ:OMER)

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Omeros trades on the NASDAQ stock market under the symbol OMER.

As of December 5, 2025, OMER stock price declined to $10.85 with 950,671 million shares trading.

OMER has a beta of 0.56, meaning it tends to be less sensitive to market movements. OMER has a correlation of 0.01 to the broad based SPY ETF.

OMER has a market cap of $769.27 million. This is considered a Small Cap stock.

Last quarter Omeros reported $0 in Revenue and -$.34 earnings per share. This fell short of revenue expectation by $-312,500 and exceeded earnings estimates by $.18.

In the last 3 years, OMER traded as high as $13.60 and as low as $.92.

The top ETF exchange traded funds that OMER belongs to (by Net Assets): IWM, VTI, IWO, VXF, SCHA.

OMER has underperformed the market in the last year with a return of -2.3%, while SPY returned +14.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in OMER shares. However, OMER has outperformed the market in the last 3 month and 2 week periods, returning +160.2% and +22.3%, while SPY returned +6.2% and +4.0%, respectively. This indicates OMER has been having a stronger performance recently.

OMER support price is $10.26 and resistance is $11.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OMER shares will trade within this expected range on the day.